Macro-Aspartate Aminotransferase Elevation in a Patient with Chronic Hepatitis B
- Author:
Nae-Yun HEO
1
;
Jae-Hoon KIM
;
Seungha PARK
;
Joon Hyuk CHOI
;
Tae Oh KIM
;
Jin LEE
;
Yong Eun PARK
;
Kyung Ran JUN
Author Information
- Publication Type:CASE REPORT
- From:The Korean Journal of Gastroenterology 2026;86(2):122-127
- CountryRepublic of Korea
- Language:English
- Abstract: Although aspartate aminotransferase (AST) is a serum marker of hepatocellular damage in chronic hepatitis, it is difficult to interpret very high AST levels with concurrent low alanine aminotransferase (ALT) levels. Macro-AST is an immunoglobulin-AST complex that can present as aberrant high enzymatic activity without significant inflammation in the liver. Two patients with chronic hepatitis B presented with disproportionate AST elevations. Their plasma samples were precipitated with polyethylene glycol (PEG) and stored at 4°C for macro-AST determinations. In Case 1, PEG precipitation showed 100% removal of AST activity, and refrigerated storage resulted in a ~70% decline over seven days, confirming macro-AST. In Case 2, both tests showed minimal changes, suggesting that macro-AST was unlikely. The AST levels normalized after antiviral therapy, suggesting immune-active hepatitis as the probable cause, but the other contributing factors could not be completely excluded. The abrupt decrease in AST activity after PEG precipitation and during refrigeration storage suggests that relatively high AST values compared to ALT might be attributed to the presence of macro-AST.These non-invasive methods for detecting macroenzymes might help the patient avoid unnecessary further work-ups.
